
MedPal AI has reported its strongest month since launch, with more than 42,250 prescription items dispensed in May and cumulative volumes now above 250,000. In this interview, CEO Jason Drummond discusses what is driving the growth, whether 34% pharmacy gross margins are sustainable, and how investors should judge the path from operational momentum to cash generation.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

2413: Is EGT now set for revenues of £50m?

2412: RentGuarantor Revenues Surge 155%

2411: Poolbeg Pharma: What US Payers Really Said

2410: Great Southern Copper targets district-scale porphyry system in Chile
Free AI-powered recaps of The Vox Markets Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.